155 related articles for article (PubMed ID: 35203731)
1. Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia-A Single Center Analysis.
Modemann F; Härterich S; Schulze Zur Wiesch J; Rohde H; Lindeman NB; Bokemeyer C; Fiedler W; Ghandili S
Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203731
[TBL] [Abstract][Full Text] [Related]
2. Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India.
Ghosh S; Chakraborty M; Samanta S; Sinha N; Saha S; Chattopadhyay A; Roy SS; Bhattacharyya M
Ann Hematol; 2021 Feb; 100(2):395-403. PubMed ID: 33140134
[TBL] [Abstract][Full Text] [Related]
3. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies-a retrospective single-centre analysis of 200 cases.
Geßner D; Berisha M; Esser T; Schalk E
Ann Hematol; 2023 Sep; 102(9):2607-2616. PubMed ID: 37186157
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Kroll AL; Corrigan PA; Patel S; Hawks KG
J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
[TBL] [Abstract][Full Text] [Related]
6. Survivorship Struggles: Navigating Etiologies and Clinical Parameters of Febrile Neutropenia During Induction Chemotherapy in Acute Leukemia Patients.
Khan MH; Wattoo MA; Butt HUR; Zaid M; Tahir U; Kaneez M; Munir Joyia U; Bukhari SF
Cureus; 2024 Feb; 16(2):e54935. PubMed ID: 38544593
[TBL] [Abstract][Full Text] [Related]
7. Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study.
Zhou XP; Ye XJ; Shen JP; Lan JP; Jiang HF; Zhang J; Zhang XJ; Li L; Qian SX; Tong HY
Leuk Lymphoma; 2018 Nov; 59(11):2679-2685. PubMed ID: 29448851
[TBL] [Abstract][Full Text] [Related]
8. [Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute Leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
Gao HH; Yao ZL; Li Y; Huang S; Liu J; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):684-690. PubMed ID: 29950204
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals.
Schwab KS; Hahn-Ast C; Heinz WJ; Germing U; Egerer G; Glasmacher A; Leyendecker C; Marklein G; Nellessen CM; Brossart P; von Lilienfeld-Toal M
Infection; 2014 Feb; 42(1):97-104. PubMed ID: 23979853
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
Lee P; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
12. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
13. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
[TBL] [Abstract][Full Text] [Related]
14. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
[TBL] [Abstract][Full Text] [Related]
16. Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia.
Yanada M; Kiyoi H; Murata M; Suzuki M; Iwai M; Yokozawa T; Baba H; Emi N; Naoe T
Intern Med; 2006; 45(5):259-64. PubMed ID: 16595990
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline resistance among Klebsiella pneumoniae isolated from febrile neutropenic patients.
Elgendy SG; Abdel Hameed MR; El-Mokhtar MA
J Med Microbiol; 2018 Jul; 67(7):972-975. PubMed ID: 29799385
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
[TBL] [Abstract][Full Text] [Related]
20. Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study.
Oyake T; Takemasa-Fujisawa Y; Sugawara N; Mine T; Tsukushi Y; Hanamura I; Fujishima Y; Aoki Y; Kowata S; Ito S; Ishida Y
Ann Hematol; 2019 May; 98(5):1209-1216. PubMed ID: 30824955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
